{"id":"https://openalex.org/W4403520046","doi":"https://doi.org/10.1007/s00403-024-03398-y","title":"Short term efficacy of biological treatment for moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis","display_name":"Short term efficacy of biological treatment for moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis","publication_year":2024,"publication_date":"2024-10-18","ids":{"openalex":"https://openalex.org/W4403520046","doi":"https://doi.org/10.1007/s00403-024-03398-y","pmid":"https://pubmed.ncbi.nlm.nih.gov/39424649"},"language":"en","primary_location":{"id":"doi:10.1007/s00403-024-03398-y","doi":"https://doi.org/10.1007/s00403-024-03398-y","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00403-024-03398-y","pdf_url":null,"source":{"id":"https://openalex.org/S33894392","display_name":"Archives of Dermatological Research","issn_l":"0003-9187","issn":["0003-9187","0340-3696","1432-069X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of Dermatological Research","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://dx.doi.org/10.21203/rs.3.rs-4692535/v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103258139","display_name":"Omar Mohammad Ismail","orcid":"https://orcid.org/0000-0003-3774-337X","observed_orcids":["https://orcid.org/0000-0003-3774-337X"]},"institutions":[{"id":"https://openalex.org/I114972647","display_name":"University of Jordan","ror":"https://ror.org/05k89ew48","country_code":"JO","type":"education","lineage":["https://openalex.org/I114972647"]}],"countries":["JO"],"is_corresponding":true,"raw_author_name":"Omar Ismail","raw_affiliation_strings":["School of Medicine, University of Jordan, Amman, 11972, Jordan. omar.moh.isml@gmail.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, University of Jordan, Amman, 11972, Jordan. omar.moh.isml@gmail.com","institution_ids":["https://openalex.org/I114972647"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030025278","display_name":"Kamel A. Jaber","orcid":"https://orcid.org/0009-0002-7179-9246","observed_orcids":["https://orcid.org/0009-0002-7179-9246"]},"institutions":[{"id":"https://openalex.org/I114972647","display_name":"University of Jordan","ror":"https://ror.org/05k89ew48","country_code":"JO","type":"education","lineage":["https://openalex.org/I114972647"]}],"countries":["JO"],"is_corresponding":false,"raw_author_name":"Kamel Jaber","raw_affiliation_strings":["School of Medicine, University of Jordan, Amman, 11972, Jordan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, University of Jordan, Amman, 11972, Jordan","institution_ids":["https://openalex.org/I114972647"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086736028","display_name":"Y. Jaber","orcid":"https://orcid.org/0009-0008-5815-8659","observed_orcids":["https://orcid.org/0009-0008-5815-8659"]},"institutions":[{"id":"https://openalex.org/I114972647","display_name":"University of Jordan","ror":"https://ror.org/05k89ew48","country_code":"JO","type":"education","lineage":["https://openalex.org/I114972647"]}],"countries":["JO"],"is_corresponding":false,"raw_author_name":"Yazan Jaber","raw_affiliation_strings":["School of Medicine, University of Jordan, Amman, 11972, Jordan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, University of Jordan, Amman, 11972, Jordan","institution_ids":["https://openalex.org/I114972647"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114315569","display_name":"Ubadah Froukh","orcid":"https://orcid.org/0009-0003-0283-8771","observed_orcids":["https://orcid.org/0009-0003-0283-8771"]},"institutions":[{"id":"https://openalex.org/I114972647","display_name":"University of Jordan","ror":"https://ror.org/05k89ew48","country_code":"JO","type":"education","lineage":["https://openalex.org/I114972647"]}],"countries":["JO"],"is_corresponding":false,"raw_author_name":"Ubadah Froukh","raw_affiliation_strings":["School of Medicine, University of Jordan, Amman, 11972, Jordan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, University of Jordan, Amman, 11972, Jordan","institution_ids":["https://openalex.org/I114972647"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110783063","display_name":"Ahmad T. Younis","orcid":"https://orcid.org/0009-0008-9257-2247","observed_orcids":["https://orcid.org/0009-0008-9257-2247"]},"institutions":[{"id":"https://openalex.org/I114972647","display_name":"University of Jordan","ror":"https://ror.org/05k89ew48","country_code":"JO","type":"education","lineage":["https://openalex.org/I114972647"]}],"countries":["JO"],"is_corresponding":false,"raw_author_name":"Ahmad Younis","raw_affiliation_strings":["School of Medicine, University of Jordan, Amman, 11972, Jordan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, University of Jordan, Amman, 11972, Jordan","institution_ids":["https://openalex.org/I114972647"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092623775","display_name":"Karam Mohannad Albdour","orcid":"https://orcid.org/0009-0006-9081-9790","observed_orcids":["https://orcid.org/0009-0006-9081-9790"]},"institutions":[{"id":"https://openalex.org/I114972647","display_name":"University of Jordan","ror":"https://ror.org/05k89ew48","country_code":"JO","type":"education","lineage":["https://openalex.org/I114972647"]}],"countries":["JO"],"is_corresponding":false,"raw_author_name":"Karam Albdour","raw_affiliation_strings":["School of Medicine, University of Jordan, Amman, 11972, Jordan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, University of Jordan, Amman, 11972, Jordan","institution_ids":["https://openalex.org/I114972647"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063408350","display_name":"Yazan M. Momani","orcid":"https://orcid.org/0009-0007-6842-5039","observed_orcids":["https://orcid.org/0009-0007-6842-5039"]},"institutions":[{"id":"https://openalex.org/I114972647","display_name":"University of Jordan","ror":"https://ror.org/05k89ew48","country_code":"JO","type":"education","lineage":["https://openalex.org/I114972647"]}],"countries":["JO"],"is_corresponding":false,"raw_author_name":"Yazan Momani","raw_affiliation_strings":["School of Medicine, University of Jordan, Amman, 11972, Jordan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, University of Jordan, Amman, 11972, Jordan","institution_ids":["https://openalex.org/I114972647"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050592216","display_name":"Noor Almaani","orcid":"https://orcid.org/0000-0003-2014-3132","observed_orcids":["https://orcid.org/0000-0003-2014-3132"]},"institutions":[{"id":"https://openalex.org/I114972647","display_name":"University of Jordan","ror":"https://ror.org/05k89ew48","country_code":"JO","type":"education","lineage":["https://openalex.org/I114972647"]}],"countries":["JO"],"is_corresponding":false,"raw_author_name":"Noor Almaani","raw_affiliation_strings":["Department of Dermatology, School of Medicine, University of Jordan, Amman, Jordan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, School of Medicine, University of Jordan, Amman, Jordan","institution_ids":["https://openalex.org/I114972647"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5103258139"],"corresponding_institution_ids":["https://openalex.org/I114972647"],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":null,"fwci":0.1129,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.09276387,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"316","issue":"10","first_page":"699","last_page":"699"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/plaque-psoriasis","display_name":"plaque psoriasis","score":0.9139999747276306},{"id":"https://openalex.org/keywords/moderate-to-severe-psoriasis","display_name":"moderate-to-severe psoriasis","score":0.9330000281333923},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.9139999747276306},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.9419999718666077},{"id":"https://openalex.org/keywords/ixekizumab","display_name":"ixekizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/brodalumab","display_name":"brodalumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/risankizumab","display_name":"risankizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ustekinumab","display_name":"ustekinumab","score":1.0},{"id":"https://openalex.org/keywords/anti-il-17-therapy","display_name":"anti-IL-17 therapy","score":0.7929999828338623},{"id":"https://openalex.org/keywords/pasi-improvement","display_name":"PASI improvement","score":0.7009999752044678},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.777999997138977},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.515999972820282}],"concepts":[{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.7082748413085938},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.6991962194442749},{"id":"https://openalex.org/C61797465","wikidata":"https://www.wikidata.org/wiki/Q1188986","display_name":"Term (time)","level":2,"score":0.6556631326675415},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6246491074562073},{"id":"https://openalex.org/C3020604521","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Plaque psoriasis","level":3,"score":0.5364407300949097},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.4576003849506378},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.44278591871261597},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.38725101947784424},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2885708510875702},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12198144197463989},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000069549","descriptor_name":"Ustekinumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000069549","descriptor_name":"Ustekinumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1007/s00403-024-03398-y","doi":"https://doi.org/10.1007/s00403-024-03398-y","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00403-024-03398-y","pdf_url":null,"source":{"id":"https://openalex.org/S33894392","display_name":"Archives of Dermatological Research","issn_l":"0003-9187","issn":["0003-9187","0340-3696","1432-069X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of Dermatological Research","raw_type":"journal-article"},{"id":"doi:10.21203/rs.3.rs-4692535/v1","doi":"https://doi.org/10.21203/rs.3.rs-4692535/v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.21203/rs.3.rs-4692535/v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},{"id":"pmid:39424649","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39424649","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of dermatological research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.21203/rs.3.rs-4692535/v1","doi":"https://doi.org/10.21203/rs.3.rs-4692535/v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.21203/rs.3.rs-4692535/v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":56,"referenced_works":["https://openalex.org/W1541270304","https://openalex.org/W1560654611","https://openalex.org/W1617328014","https://openalex.org/W1877047792","https://openalex.org/W1940145814","https://openalex.org/W1975162362","https://openalex.org/W1975463338","https://openalex.org/W1975900036","https://openalex.org/W1977207218","https://openalex.org/W2008716526","https://openalex.org/W2013361256","https://openalex.org/W2023039127","https://openalex.org/W2024626717","https://openalex.org/W2029890079","https://openalex.org/W2030348118","https://openalex.org/W2031157372","https://openalex.org/W2055018575","https://openalex.org/W2057014857","https://openalex.org/W2060546762","https://openalex.org/W2063627867","https://openalex.org/W2088155036","https://openalex.org/W2091442391","https://openalex.org/W2094124191","https://openalex.org/W2098835966","https://openalex.org/W2126798127","https://openalex.org/W2133696182","https://openalex.org/W2145778588","https://openalex.org/W2146843653","https://openalex.org/W2155798268","https://openalex.org/W2163232748","https://openalex.org/W2165657093","https://openalex.org/W2168698481","https://openalex.org/W2172257129","https://openalex.org/W2173172189","https://openalex.org/W2247689163","https://openalex.org/W2279408238","https://openalex.org/W2323903826","https://openalex.org/W2409538380","https://openalex.org/W2470133599","https://openalex.org/W2510661649","https://openalex.org/W2512942811","https://openalex.org/W2766211624","https://openalex.org/W2808102618","https://openalex.org/W2907578152","https://openalex.org/W2932510340","https://openalex.org/W2970684805","https://openalex.org/W3000497236","https://openalex.org/W3019350884","https://openalex.org/W3022535232","https://openalex.org/W3035106892","https://openalex.org/W3036055555","https://openalex.org/W3099906708","https://openalex.org/W3113161927","https://openalex.org/W4226137960","https://openalex.org/W4327640222","https://openalex.org/W4383998038"],"related_works":["https://openalex.org/W3036523869","https://openalex.org/W1967011324","https://openalex.org/W3115313036","https://openalex.org/W1970374211","https://openalex.org/W1984399057","https://openalex.org/W3149331822","https://openalex.org/W6887571320","https://openalex.org/W1557928409","https://openalex.org/W7170137879","https://openalex.org/W7147305106"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Psoriasis":[2],"is":[3,9,218],"a":[4,67],"chronic":[5],"inflammatory":[6],"disease":[7],"that":[8,78,91],"debilitating,":[10],"particularly":[11],"in":[12,22,54,82,108,131,194,204],"its":[13,33,37],"more":[14],"severe":[15],"forms.":[16],"Multiple":[17,59],"systemic":[18],"therapies":[19],"are":[20],"used":[21],"moderate-to-severe":[23,55,83],"psoriasis,":[24,199],"but":[25],"the":[26,42,47,98,128,148,157,191,196,212],"development":[27],"of":[28,46,101,198],"biological":[29,49,80],"interventions":[30,50],"has":[31],"revolutionized":[32],"management":[34],"and":[35,44,66,124,134,139,153,173,187,222,239],"improved":[36],"outcomes.":[38],"Aim":[39],"To":[40,171,176],"compare":[41],"effectiveness":[43],"safety":[45],"different":[48],"approved":[51],"for":[52,63],"use":[53],"plaque":[56],"psoriasis.":[57,84],"Methods":[58],"databases":[60],"were":[61,156,189,202],"searched":[62],"relevant":[64],"articles":[65],"prospectively":[68],"planned":[69],"network":[70],"meta-analysis":[71],"was":[72],"conducted":[73],"on":[74,105,211],"randomized":[75],"controlled":[76],"trials":[77,90],"assessed":[79],"treatments":[81],"Results":[85],"The":[86],"search":[87],"yielded":[88],"84":[89],"encompassed":[92],"39798":[93],"patients.":[94],"Infliximab":[95,188],"5mg/kg":[96],"had":[97,127],"highest":[99,129],"probability":[100,130],"achieving":[102,132,205],"75%":[103],"reduction":[104],"PASI":[106,213],"scale":[107],"comparison":[109],"to":[110,166,183],"placebo":[111],"(RR":[112],"=":[113,116],"18.76,":[114],"95%CI":[115],"[12.31;":[117],"28.57],":[118],"high":[119],"certainty),":[120],"while":[121],"Ixekizumab":[122],"80mg":[123],"Brodalumab":[125],"210mg":[126],"PASI90":[133],"PASI100":[135],"(37.81,":[136],"[28.57;":[137],"50.03]":[138],"81.04,":[140],"[26.16;":[141],"251.01],":[142],"respectively,":[143],"with":[144,160,179],"moderate":[145],"certainty)":[146,181],"On":[147],"other":[149],"hand,":[150],"Risankizumab":[151],"150mg":[152],"Ustekinumab":[154],"90mg":[155],"only":[158],"regimens":[159],"significantly":[161],"less":[162],"withdrawal":[163],"rates":[164],"due":[165],"adverse":[167],"events":[168],"(0.41,":[169],"[0.18":[170],"0.96],":[172],"0.57,":[174],"[0.35":[175],"0.91],":[177],"respectively":[178],"High":[180],"compared":[182],"placebo.":[184],"Conclusion":[185],"Anti-IL17":[186],"among":[190],"most":[192],"effective":[193],"ameliorating":[195],"symptoms":[197],"however,":[200],"anti-IL17":[201],"better":[203],"full":[206,209],"or":[207],"almost":[208],"improvement":[210],"scale.":[214],"Real":[215],"life":[216],"decision-making":[217],"not":[219],"so":[220],"clear-cut":[221],"should":[223],"remain":[224],"patient":[225],"centered,":[226],"taking":[227],"into":[228],"consideration":[229],"factors":[230],"such":[231],"as":[232],"safety,":[233],"comorbidities,":[234],"biologic":[235],"naivety,":[236],"dosing":[237],"preferences":[238],"insurance":[240],"considerations.":[241]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2}],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2024-10-18T00:00:00"}